WHO approves emergency use of serum’s Covovax vaccine, Poonawalla declared a big victory

▪️WHO approves emergency use for Covovax vaccine
▪️Serum Institute of Poonawalla has Covovax vaccine

Amid the Omicron threat, the WHO has approved the Serum Institute’s vaccine, Covovax, for emergency use. Adar Poonawalla has given information about this decision by tweeting. He has told that another big decision has been taken in the battle of Corona. He told that the Covovax vaccine is more effective and safe.

WHO approves emergency use for Covovax vaccine

For information, let us tell you that the Kovovax vaccine has been prepared by Serum in association with the Novavax company. All the trials that have been done so far, this vaccine has proved to be very effective. For this reason, WHO has approved the 9th vaccine for emergency use. WHO says that low-income countries will benefit greatly from these vaccines and there will be rapid vaccination in a short time.

This is yet another milestone in our fight against COVID-19, Covovax is now W.H.O. approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration, @Novavax @WHO @GaviSeth @Gavi @gatesfoundation https://t.co/7C8RVZa3Y4

— Adar Poonawalla (@adarpoonawalla) December 17, 2021

In this regard, Dr Mariângela Simão of the WHO says that among the new variants, the vaccine is the only effective tool that can protect people from serious diseases. He also said that the Covovax vaccine has been approved to improve the vaccination situation in low-income countries. According to him, there are 41 countries where less than 10 percent vaccination is still going on, while 98 countries have also come to the fore where the figure of 40 percent has not been touched.

Will wait for full license

By the way, some time ago, this vaccine of Novavax-SII has also been approved for emergency use in Indonesia and Philippines. In India too, an application has been made for emergency use. The company has made it clear that the Kovovax vaccine is going to play a decisive role in the fight against Corona.

Talking about the Covovax vaccine, it can be kept in a temperature of 2 to  8 °C. This vaccine will have more effect when two doses of it are given. By the way, this serum vaccine has also been given a green signal when the results of its Phase 2 and 3 trials were studied thoroughly. After a lot of research, many experts and the WHO team have approved the Covovax vaccine for emergency use. But for the full license now, the company will have to continuously give the necessary data related to the vaccine to the WHO.